The Application of Digital Morphology in Haematology Education. Barbara De la Salle Deputy Director UK NEQAS General Haematology

Size: px
Start display at page:

Download "The Application of Digital Morphology in Haematology Education. Barbara De la Salle Deputy Director UK NEQAS General Haematology"

Transcription

1 The Application of Digital Morphology in Haematology Education Barbara De la Salle Deputy Director UK NEQAS General Haematology

2 8 November, 2011 UK National External Quality Assessment Service comprises a network of 144 schemes operating from 24 centres based at major hospitals, research institutions and universities throughout the UK

3 West Herts Hospitals Trust

4

5 Digital Slides All view the same cell(s) Microscopy vs morphology skills Direct annotation: education/training Relatively low cost Viewable by limitless numbers Easy to store

6 Hutchinson CV et al Clin Lab Haem (2005)

7 Patient Details Age (yrs) Sex Hb(g/l) WBC(x10 9 /l) Platelets (x10 9 /l) 55 f Expert Comment (Dr J Parker-Williams, Scheme Director, UK NEQAS) This film was prepared from a blood specimen taken from a fifty-five-year-old-lady, who was diagnosed with myelofibrosis in This is a film with complex morphological abnormalities - too many to score as many stated! Myelofibrosis was diagnosed in 1992; a splenectomy was performed in 1996 for increasing splenomegaly; twenty percent of participants recorded features of hyposplenism. The majority felt that the features were those of a myeloproliferative/myelodysplastic disorder with transformation to AML-M7. The five most commonly reported features were: Nucleated red cells Blast cells Macrocytic platelets Myelocytes Megakaryocyte fragments.

8 2004 Exercise: stitched images

9 2004: Rate the Exercise With thanks to Michelle Brereton, Manchester Royal Infirmary

10 Feedback 2004: High quality, large scale, stitched slides Easy to use software Educational content Access for more participants

11 Photograph single high power images

12 Take multiple overlapping fields

13 Computer software matches fields

14 While still retaining details that can be viewed at high power

15 2007: UK NEQAS / SlidePath not for profit collaboration UK NEQAS images Digital Slidebox software Secure, on-line, individual participation

16

17 Digital Morphology CPD Scheme Launched April 2008 Individual participation Educational in purpose 6 cases per year 2000 individual licenses returns per case Laboratory manager admin pages 2011 Additional educational content for 2012

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34 Feedback from users It is a relatively effortless way for my staff to create evidence of CPD This strengthens the knowledge of all of my staff and improves their validation knowledge It s more personal and removes some of the pressure of similar schemes. It is more comfortable for less experienced staff to participate

35 Cases issued

36 First Case DM1 Previous UK NEQAS 0507BF2 37 year old, female, SE Asia Hepatosplenomegaly, transfused Hb 7.2 g/dl, RBC 4.36, MCV 55, MCH 17 DIAGNOSIS Complex haemoglobinopathy: Hb A + Hb E + Hb Barts Disease

37 Top 5 Features 0801DM1 Glass slide Digital slide 1 Target cells Target cells 2 Hypochromic RBC Punctate basophilia 3 Tear drop poikilocytes Tear drop poikilocytes 4 Punctate basophilia RBC fragments etc 5 Poikilocytes Hypochromic RBC

38 Second Case DM1 Previous UK NEQAS 0505BF1 83 year old, female Transient ischaemic attack, angina, hypertension Hb 11.2 g/dl, WBC 138, Platelets 7 DIAGNOSIS Lymphoproliferative disorder: T-PLL

39 Top 5 Features 0802DM1 Glass slide Digital slide 1 Thrombocytopenia Thrombocytopenia 2 Lymphocytosis Lymphocytosis 3 Smear/smudge cells Smear/smudge cells 4 Prolymphocytes Cleft nuclei 5 Cleft nuclei Neutropenia

40 Questionnaire completed survey Overall feedback was positive with several good suggestions on improvement

41 Participant groups surveyed 2% 14% 2% 11% Laboratory Manager Chief or Senior BMS Specialist BMS 36% Basic grade BMS Generic/ non Specialist BMS. Trainee BMS 35% Other (please specify)

42 Type of organisation 2% 6% 26% Teaching District General Private Other (please specify) 66%

43 Background Haematology 37.7% Haematology/Transfusion 50.5% Blood transfusion 5.5% Combined Blood Sciences 4.5% Others 1.8% Leukaemia diagnosis Stem Cell Laboratory Haemato-Oncology

44 Morphology Experience How much morphology experience do you have? 70.0% 60.0% 50.0% 40.0% 30.0% 20.0% 10.0% 0.0% Report under supervision Regularly issue reports Issue reports out of hours Occasionally report films Not currently practising Series1 6.0% 59.3% 13.7% 16.2% 4.7%

45 Quality of DM Process Very good/good (%) Very poor/poor (%) 120 Good/Very Good (%) Poor/Very Poor(%) Range of cases Quality of images Stain quality Case questions Range of cases Quality of images Stain quality Case questions

46 Cases: viewed / completed 30.0% How many cases completed % How many cases viewed % 25.0% 20.0% 15.0% 10.0% 5.0% How many cases completed % 0.0% How many cases viewed % None >7 3.9% 17.6% 23.0% 19.1% 17.9% 18.5% 1.5% 15.7% 20.5% 19.3% 18.4% 24.5%

47 Lab Managers: 87% - Registration is easy 70% - Want on-line management and to track staff participation

48 UK NEQAS Digital Morphology Workshop participants, all DM users 95% rated the educative morphology narrative as useful 76% liked comparison of their results against others 70% felt the programme met their expectations

49 Collaborative Activities British Society for Haematology slide sessions Institute of Biomedical Science slide sessions International Society for Laboratory Haematology morphology workshop 2008 World Health Organisation photo-gallery

50 Conclusions Novel educational programme for laboratory scientists High level of satisfaction with quality and case mix Demonstrated increased confidence amongst participants: % offered a diagnosis % offered a diagnosis

51 Finally.. I have just completed the first module of the scheme and I must say that I have found it very informative and instructive, even for someone with my experience. The website was very clear to navigate around and the quality of the images was excellent. The teaching input was very comprehensive and has proved to be of great benefit and interest to all my staff taking part. Many thanks for what promises to be an innovative and instructive scheme. A participant s comment

52 Acknowledgements Manchester Royal Infirmary, UK Michelle Brereton, John Burthem, John Ardern UK NEQAS General Haematology staff and advisors Zuotimi Eke, John Parker-Williams, Keith Patterson, Paul McTaggart, Mary West, Keith Hyde Manchester Universities, UK Len Seal, Laura Tatum UK NEQAS participants

53

Barbara De la Salle Director, UK NEQAS Haematology

Barbara De la Salle Director, UK NEQAS Haematology Barbara De la Salle Director, UK NEQAS Haematology UK NEQAS Haematology developments (with apologies to Ian Mellors) UKAS assessors ISO15189 (Laboratories) ISO17043 (Scheme) Oversight bodies (NQAAP) Strategic

More information

UK NEQAS for General Haematology Annual Report January December 2010

UK NEQAS for General Haematology Annual Report January December 2010 UK NEQAS for General Haematology Annual Report January December 00 February 0 Scheme Director: Scheme Manager: Professor Keith Hyde Mrs Barbara De la Salle UK NEQAS (H) PO Box 4 Watford WD8 0FJ United

More information

Laboratory for diagnosis of THALASSEMIA

Laboratory for diagnosis of THALASSEMIA SCBM343 CLINICAL PATHOLOGY 2(1-2-3) Laboratory for diagnosis of THALASSEMIA PORNTHIP CHAICHOMPOO pornthip.chh@mahidol.ac.th Acknowledgements Dr. Pranee Winichagoon Fucharoen Ms. Pornnapa Khampan Thalassemia

More information

Leukocytosis - Some Learning Points

Leukocytosis - Some Learning Points Leukocytosis - Some Learning Points Koh Liang Piu Department of Hematology-Oncology National University Cancer Institute National University Health System Objectives of this talk: 1. To provide some useful

More information

MYELOPROLIFARATIVE NEOPLASMS. Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin).

MYELOPROLIFARATIVE NEOPLASMS. Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin). MYELOPROLIFARATIVE NEOPLASMS Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin). These are a group of chronic conditions characterised by clonal proliferation of marrow precursor cells. PRV, essential thrombocyathaemia,

More information

Full Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa

Full Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa Full Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa The Role of the FBC in clinical decision making History Examination Investigations Decision 70% FBC Laboratory

More information

Maggie Keswick Jencks Cancer Caring Centres Trust Job Description. In accordance with Maggie s policies and procedures

Maggie Keswick Jencks Cancer Caring Centres Trust Job Description. In accordance with Maggie s policies and procedures Maggie Keswick Jencks Cancer Caring Centres Trust Job Description 1. JOB TITLE: Cancer Support Specialist REPORTS TO: PROFESSIONAL SUPERVISION: Centre Head In accordance with Maggie s policies and procedures

More information

Polycthemia Vera (Rubra)

Polycthemia Vera (Rubra) Polycthemia Vera (Rubra) Polycthemia Vera (Rubra) Increased red cells Clonal Myeloid lineages also increased 2-13 cases per million Mean age: 60 years Sites of Involvement Bone marrow Peripheral blood

More information

HEFT Pathology Guideline. GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia

HEFT Pathology Guideline. GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia HEFT Pathology Guideline GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia Produced by: Dr Charalampos Kartsios (Consultant Haematologist) and Muhammad Javed

More information

Year 2003 Paper two: Questions supplied by Tricia

Year 2003 Paper two: Questions supplied by Tricia QUESTION 65 A 36-year-old man presents in a post-ictal state after an observed generalised seizure. Full blood investigation shows: haemoglobin 0 g/l [128-175] mean corpuscular volume (MCV) 106 fl [80-7]

More information

Chronic Idiopathic Myelofibrosis (CIMF)

Chronic Idiopathic Myelofibrosis (CIMF) Chronic Idiopathic Myelofibrosis (CIMF) CIMF Synonyms Agnogenic myeloid metaplasia Myelosclerosis with myeloid metaplasia Chronic granulocytic-megakaryocytic myelosis CIMF Megakaryocytic proliferation

More information

Development of a Blood Transfusion Knowledge Based Competency Assessment Scheme

Development of a Blood Transfusion Knowledge Based Competency Assessment Scheme Development of a Blood Transfusion Knowledge Based Competency Assessment Scheme Clare Milkins Jenny White Bill Chaffe Scheme Manager Deputy Scheme Manager Senior EQA Scientist Why the perceived need? (Mis)-use

More information

Maggie Keswick Jencks Cancer Caring Centres Trust Job Description. 1. JOB TITLE: Cancer support specialist. procedures

Maggie Keswick Jencks Cancer Caring Centres Trust Job Description. 1. JOB TITLE: Cancer support specialist. procedures Maggie Keswick Jencks Cancer Caring Centres Trust Job Description 1. JOB TITLE: Cancer support specialist REPORTS TO: PROFESSIONAL SUPERVISION: RESPONSIBLE FOR: LIAIASES WITH: Centre Head In accordance

More information

External Quality Assurance in Genetics Laboratories

External Quality Assurance in Genetics Laboratories Genetics Quality and Accreditation workshop External Quality Assurance in Genetics Laboratories Farrah Khawaja Deputy Scheme Director UK NEQAS for Molecular Genetics The Royal Infirmary of Edinburgh Molecular

More information

School of Improvement Supporting trainees from Students to Consultants

School of Improvement Supporting trainees from Students to Consultants School of Improvement Supporting trainees from Students to Consultants 2018 Prospectus Welcome to the School of Improvement Guy s and St Thomas NHS Foundation Trust is one of the largest teaching hospitals

More information

Perspective on performance: The Haemoglobinopathies. Barbara Wild

Perspective on performance: The Haemoglobinopathies. Barbara Wild Perspective on performance: The Haemoglobinopathies Barbara Wild Perspective on Performance: Performance assessment process DNA diagnostics for Haemoglobinopathies scheme Outcomes of shadow scoring exercise

More information

Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust

Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust Regional Paediatric Specialty Trainees teaching 4 th July 2017 Scope

More information

Myelodysplastic syndrome (MDS) & Myeloproliferative neoplasms

Myelodysplastic syndrome (MDS) & Myeloproliferative neoplasms Myelodysplastic syndrome (MDS) & Myeloproliferative neoplasms Myelodysplastic syndrome (MDS) A multipotent stem cell that can differentiate into any of the myeloid lineage cells (RBCs, granulocytes, megakaryocytes)

More information

Continuing Education Questions

Continuing Education Questions FOCUS: INTERPRETING THE COMPLETE BLOOD COUNT Continuing Education Questions SUMMER 2017 1. A methodical approach to CBC interpretation that is aimed at medical laboratory professionals differs from one

More information

Institute of Psychiatry, Psychology & Neuroscience

Institute of Psychiatry, Psychology & Neuroscience Maudsley International a specialist mentalhealth and wellbeing consultancy Maudsley International is an expert organisation that helps its clients develop and improve services and support for people who

More information

The audit is managed by the Royal College of Psychiatrists in partnership with:

The audit is managed by the Royal College of Psychiatrists in partnership with: Background The National Audit of Dementia (NAD) care in general hospitals is commissioned by the Healthcare Quality Improvement Partnership on behalf of NHS England and the Welsh Government, as part of

More information

Haematology dilemma s to refer or not to refer?

Haematology dilemma s to refer or not to refer? Haematology dilemma s to refer or not to refer? NWL Pathology GP Study Day Dr Fatts Chowdhury Consultant Haematologist in Transfusion Medicine NHS Blood and Transplant Senior Honorary Clinical Lecturer

More information

Hematopathology Case Study

Hematopathology Case Study Hematopathology Case Study AMP Outreach Course 2009 AMP Annual Meeting John Greg Howe Ph.D. Department of Laboratory Medicine Yale University School of Medicine November 19, 2009 HISTORY Case History An

More information

FBC interpretation. Dr. Gergely Varga

FBC interpretation. Dr. Gergely Varga FBC interpretation Dr. Gergely Varga #1 71 Y/O female, c/o weakness Test Undertaken : FBC (FBC) Sample Type: Whole Blood [ - 26.09.11 14:59] Hb 7.3 g/dl* 12.0-15.5 RBC 3.5 10^12/l * 3.80-5.60 Hct 0.24

More information

Complete Blood Count in Primary Care

Complete Blood Count in Primary Care QUIZ FEEDBACK Complete Blood Count in Primary Care bpac nz better medicine GP Review Panel: Dr Janine Bailey, Motueka Dr Susie Lawless, Dunedin Dr Randall Sturm, Auckland Dr Neil Whittaker, Nelson Specialist

More information

Survey of local governors associations 2014

Survey of local governors associations 2014 Survey of local governors associations 2014 Thank you to the 30 local associations that took part in our survey. This represents just under half of the local associations who are in membership of National

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA) Ruxolitinib for the treatment of myelofibrosis

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA) Ruxolitinib for the treatment of myelofibrosis Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS. Healthcare professionals can provide a unique perspective on the technology

More information

Interpreting Hematology Scatter-Plots; One Cancer Center s Keys to Seeing the BIG Picture

Interpreting Hematology Scatter-Plots; One Cancer Center s Keys to Seeing the BIG Picture Interpreting Hematology Scatter-Plots; One Cancer Center s Keys to Seeing the BIG Picture Barbara L. Burch, MHA MT (ASCP) Laboratory Manager New York University Clinical Cancer Center Disclosure Ms Burch

More information

CRITERIA FOR CREDENTIALLING A PAEDIATRIC HAEMATOLOGIST- ONCOLOGIST IN THE MALAYSIAN SPECIALIST REGISTER

CRITERIA FOR CREDENTIALLING A PAEDIATRIC HAEMATOLOGIST- ONCOLOGIST IN THE MALAYSIAN SPECIALIST REGISTER Page 10f8 REVISED (29-8-09) CRITERIA FOR CREDENTIALLING A PAEDIATRIC HAEMATOLOGIST- ONCOLOGIST IN THE MALAYSIAN SPECIALIST REGISTER The criteria are as follows: 1. A basic medical degree recognised by

More information

National Horizon Scanning Centre. Azacitidine (Vidaza) for myelodysplastic syndrome. September 2007

National Horizon Scanning Centre. Azacitidine (Vidaza) for myelodysplastic syndrome. September 2007 Azacitidine (Vidaza) for myelodysplastic syndrome September 2007 This technology summary is based on information available at the time of research and a limited literature search. It is not intended to

More information

MDS 101. What is bone marrow? Myelodysplastic Syndrome: Let s build a definition. Dysplastic? Syndrome? 5/22/2014. What does bone marrow do?

MDS 101. What is bone marrow? Myelodysplastic Syndrome: Let s build a definition. Dysplastic? Syndrome? 5/22/2014. What does bone marrow do? 101 May 17, 2014 Myelodysplastic Syndrome: Let s build a definition Myelo bone marrow Gail J. Roboz, M.D. Director, Leukemia Program Associate Professor of Medicine What is bone marrow? What does bone

More information

The Liverpool Hands On Cardiac Pacing Course

The Liverpool Hands On Cardiac Pacing Course The Liverpool Hands On Cardiac Pacing Course Venue: Hilton Hotel, Liverpool th th 18 & 19 June, 2018 Director Dr Khaled Albouaini, Consultant Cardiologist Royal Liverpool University Hospital & Liverpool

More information

Pathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16

Pathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16 35 Pathology #11 Acute Leukemias Farah Banyhany Dr. Sohaib Al- Khatib 23/2/16 1 Salam First of all, this tafreegh is NOT as long as you may think. If you just focus while studying this, everything will

More information

Candidates must answer ALL questions

Candidates must answer ALL questions Time allowed: Three hours. Part 1 examination Haematology: First paper Tuesday 22 March 2016 Candidates must answer ALL questions Question 1: General Haematology A 16 year old non-european is referred

More information

Case Presentation No. 075

Case Presentation No. 075 Case Presentation No. 075 Session 4. Myelodysplastic Syndrome Cristina Montalvo, MD Baylor College of Medicine Houston, Texas 2007 Workshop of Society for Hematopathology and European Association for Haematopathology

More information

Rory McCulloch. Specialty Trainee Haematology Royal Devon & Exeter Hospital

Rory McCulloch. Specialty Trainee Haematology Royal Devon & Exeter Hospital Rory McCulloch Specialty Trainee Haematology Royal Devon & Exeter Hospital Anaemia 1 Haematological disorders Anaemia 2 Non-haematological disorders Substrates: Iron, folate, vitamin B12 Red cell mass

More information

Hassan Eliwan. MBBch, MRCP, MRCPCH (UK)

Hassan Eliwan. MBBch, MRCP, MRCPCH (UK) MBBch, MRCP, MRCPCH (UK) 1 Personal details Name Home Address: Work Address: E mail: Hassan Omran Eliwan. 65 Crescent Building, Park West Pointe, Park West, Ireland Our Lady s Children Hospital Crumlin

More information

NEW YORK STATE CYTOHEMATOLOGY PROFICIENCY TEST PROGRAM Glass Slide - November 2016

NEW YORK STATE CYTOHEMATOLOGY PROFICIENCY TEST PROGRAM Glass Slide - November 2016 NEW YORK STATE CYTOHEMATOLOGY PROFICIENCY TEST PROGRAM Glass Slide - November 2016 Results from this proficiency test event are available at: http://www.wadsworth.org/regulatory/clep/pt/summaries SLIDE

More information

FBC CASES Vernon Louw Clinical Haematology 2010

FBC CASES Vernon Louw Clinical Haematology 2010 FBC CASES Vernon Louw Clinical Haematology 2010 FOR EACH OF THE FOLLOWING PATIENTS, SELECT THE MOST LIKELY FINDING FROM THE ANALYSIS OF THE PERIPHERAL BLOOD. A patient with infectious mononucleosis. A

More information

Hematology Unit Lab 2 Review Material

Hematology Unit Lab 2 Review Material Objectives Hematology Unit Lab 2 Review Material - 2018 Laboratory Instructors: 1. Assist students during lab session Students: 1. Review the introductory material 2. Study the case histories provided

More information

Blood Cell Identification Graded

Blood Cell Identification Graded BCP-21 Blood Cell Identification Graded Case History The patient is a 37-year-old female with a history of multiple sickle cell crises. She now presents with avascular necrosis of the left hip. Laboratory

More information

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL LEUKEMIA FORMS CHAPTER 16A REVISED: DECEMBER 2017

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL LEUKEMIA FORMS CHAPTER 16A REVISED: DECEMBER 2017 LEUKEMIA FORMS The guidelines and figures below are specific to Leukemia studies. The information in this manual does NOT represent a complete set of required forms for any leukemia study. Please refer

More information

BUSINESS PLAN Association name: Association of Sickle Cell sufferers of Yorkshire for Africa and Basic Information or ASYABI

BUSINESS PLAN Association name: Association of Sickle Cell sufferers of Yorkshire for Africa and Basic Information or ASYABI C/O Retas The Roundhay Road Resource Centre 233-237 Roundhay Road Harehills Leeds, LS8 4HS Tel.: 07856978722 Email.:sicklecellyorkshireasyabi@yahoo.fr Website: www.asyabi.co.uk Registered Charity Number

More information

AIMS FELLOWSHIP CURRICULUM HAEMATOLOGY III

AIMS FELLOWSHIP CURRICULUM HAEMATOLOGY III AIMS FELLOWSHIP CURRICULUM HAEMATOLOGY III Module Title: Module Code: Module Convenor: Discipline Committee: Advanced Cellular Haematology HAEM III Haematology Department St Vincent's Hospital Darlinghurst

More information

Evaluation of UK NEQAS (H) Hb A 2 and related performance data

Evaluation of UK NEQAS (H) Hb A 2 and related performance data Evaluation of UK NEQAS (H) Hb A 2 and related performance data Hannah Batterbee 1, Barbara De la Salle 2, Paul McTaggart 2, Caroline Doré 3, Barbara Wild 4 and Keith Hyde 2 1 Haematology Department, Royal

More information

Drop of Blood Unravels Mysteries. Prof. Salma Afrose Department of Hematology Dhaka Medical College

Drop of Blood Unravels Mysteries. Prof. Salma Afrose Department of Hematology Dhaka Medical College Drop of Blood Unravels Mysteries Prof. Salma Afrose Department of Hematology Dhaka Medical College Peripheral Blood Film (PBF) PBF is a laboratory workup that involves cytology of Peripheral blood cell

More information

Symptoms and Signs in Hematology/ 2013

Symptoms and Signs in Hematology/ 2013 Symptoms and Signs in Hematology/ 2013 Abdallah Abbadi.MD.FRCP Professor of Hematology & Oncology University of Jordan & JUH Email: abdalla.awidi@gmail.com Diseases of Blood & Blood forming organs A- Benign

More information

GOVERNING BODY REPORT

GOVERNING BODY REPORT GOVERNING BODY REPORT DATE OF MEETING: 20th September 2012 TITLE OF REPORT: KEY MESSAGES: NHS West Cheshire Clinical Commissioning Group has identified heart disease as one of its six strategic clinical

More information

Haematologist-reviewed peripheral blood smear in paediatric practice

Haematologist-reviewed peripheral blood smear in paediatric practice Singapore Med J 2018; 59(2): 64-68 https://doi.org/10.11622/smedj.2018013 Haematologist-ed peripheral blood smear in paediatric practice Anselm Chi-wai Lee, MBBS, FAMS ABSTRACT Manual examination of the

More information

The patient had a mild splenomegaly but no obvious lymph node enlargement. The consensus phenotype obtained from part one of the exercise was:

The patient had a mild splenomegaly but no obvious lymph node enlargement. The consensus phenotype obtained from part one of the exercise was: Case History An 86 year old male was admitted to hospital with chest infection. Haematological examination subsequently revealed the following: Hb- 11.0 g/dl; WBC- 67.1 x 10^9/l; PLT- 99 x10^9/l; RBC-

More information

Our Summary Annual Report and Quality Account for 2015/16. gmw.nhs.uk

Our Summary Annual Report and Quality Account for 2015/16. gmw.nhs.uk Our Summary Annual Report and Quality Account for 2015/16 gmw.nhs.uk Reporting back, Looking Forward 3 Reporting Back 2015/16 has continued to see significant challenge facing the NHS nationally, and

More information

Arts Award Shared Offer Project

Arts Award Shared Offer Project Creative Projects at Roundhouse, 2014. Photo: Ali Painter Arts Award Shared Offer Project Introduction In our roles as Arts Council England Associate Bridge Organisations for London, Roundhouse and Sadler

More information

Morphology Case Study. Presented by Niamh O Donnell, BSc, MSc. Medical Scientist Haematology Laboratory Cork University Hospital

Morphology Case Study. Presented by Niamh O Donnell, BSc, MSc. Medical Scientist Haematology Laboratory Cork University Hospital Morphology Case Study Presented by Niamh O Donnell, BSc, MSc. Medical Scientist Haematology Laboratory Cork University Hospital 41 year old male presented to GP for routine check-up in May 2011. FBC Results:

More information

Draft Falls Prevention Strategy

Draft Falls Prevention Strategy Cheshire West & Chester Council Draft Falls Prevention Strategy 2017-2020 Visit: cheshirewestandchester.gov.uk Visit: cheshirewestandchester.gov.uk 02 Cheshire West and Chester Council Draft Falls Prevention

More information

Haematology and Haematological Oncology

Haematology and Haematological Oncology Haematology and Haematological Oncology Updated on 23 Feb 2017 I) OBJECTIVES 1. To provide a broad training and in-depth experience at a level sufficient for trainees to acquire competence and professionalism

More information

10:00 Chair s welcome and opening remarks Richard Caulfield, Regional Director, Association of Colleges

10:00 Chair s welcome and opening remarks Richard Caulfield, Regional Director, Association of Colleges Programme 09:15 Registration and refreshments 10:00 Chair s welcome and opening remarks 10:15 Transforming children and young people s mental health provision Barbara Rayment, Head of Policy, Children

More information

Inventory Practice Survey 2008 Report - Headline summary

Inventory Practice Survey 2008 Report - Headline summary Inventory Practice Survey 2008 Report - Headline summary Making the most of the BSMS 64% of hospitals use senior BMS to enter data Almost 80 enter stock data at least on a weekly basis Nearly a third of

More information

Clinical Guidelines for Leukaemia and other Myeloid Disorders MDS

Clinical Guidelines for Leukaemia and other Myeloid Disorders MDS Clinical Guidelines for Leukaemia and other Myeloid Disorders MDS Reference Number Version Status Executive Lead(s) Name and Job Title Author(s) Name and Job Title 13-2H-106 2 Dr Helen Barker MDT Lead

More information

South East Dermatology Transformation and Sustainability Network Thursday 19 th April 2018 Holiday Inn Guildford

South East Dermatology Transformation and Sustainability Network Thursday 19 th April 2018 Holiday Inn Guildford South East Dermatology Transformation and Sustainability Network Thursday 19 th April 2018 Holiday Inn Guildford The regional Transformation and Sustainability Network meetings are initiated and organised

More information

Therapeutic Apheresis Services Annual Review 2016/17

Therapeutic Apheresis Services Annual Review 2016/17 Therapeutic Apheresis Services Annual Review 2016/17 NHS Blood and Transplant (NHSBT) is a major provider of Therapeutic Apheresis Services (TAS) in the NHS. Services are provided across England. Collection

More information

CPD profile. 1.1 Full name: Clinical Biochemist 1.2 Profession: Clinical scientist 1.3 Registration number: CSXXXX. 2. Summary of recent work/practice

CPD profile. 1.1 Full name: Clinical Biochemist 1.2 Profession: Clinical scientist 1.3 Registration number: CSXXXX. 2. Summary of recent work/practice CPD profile 1.1 Full name: Clinical Biochemist 1.2 Profession: Clinical scientist 1.3 Registration number: CSXXXX 2. Summary of recent work/practice The Trust I work at consists of two hospitals. As a

More information

R e s e a r c h S t r a t e g y

R e s e a r c h S t r a t e g y Sheffield Teaching Hospitals NHS Foundation Trust Academic Directorate of Specialised Cancer R e s e a r c h S t r a t e g y Academic Directorate of Specialised Cancer Research Strategy Executive Summary

More information

Borderline cytopenias. Dr Taku Sugai Consultant Haematologist

Borderline cytopenias. Dr Taku Sugai Consultant Haematologist Borderline cytopenias Dr Taku Sugai Consultant Haematologist Borderline cytopenias Neutropenia Thrombocytopenia Anaemia with normal haematinics Two recent cases of cytopenias Neutropenia ANC of more than

More information

MDS: Who gets it and how is it diagnosed?

MDS: Who gets it and how is it diagnosed? MDS: Who gets it and how is it diagnosed? October 16, 2010 Gail J. Roboz, M.D. Director, Leukemia Program Associate Professor of Medicine Weill Medical College of Cornell University The New York Presbyterian

More information

Myeloproliferative Disorders - D Savage - 9 Jan 2002

Myeloproliferative Disorders - D Savage - 9 Jan 2002 Disease Usual phenotype acute leukemia precursor chronic leukemia low grade lymphoma myeloma differentiated Total WBC > 60 leukemoid reaction acute leukemia Blast Pro Myel Meta Band Seg Lymph 0 0 0 2

More information

TPS Connects. Conference 2011

TPS Connects. Conference 2011 TPS Connects Conference 011 Bringing everyone together Turning Point Scotland s strap line states that it provides person centred support to adults with a range of complex needs. But how do we make person-centred

More information

Genetics of Thalassemia

Genetics of Thalassemia Genetics of Thalassemia Submitted by : Raya Samir Al- Hayaly Sura Zuhair Salih Saad Ghassan Al- Dulaimy Saad Farouq Kassir Sama Naal Salouha Zahraa Jasim Al- Aarajy Supervised by : Dr. Kawkab Adris Mahmod

More information

MadLab // Annual Survey, Postcode Survey, & Community Group Audit

MadLab // Annual Survey, Postcode Survey, & Community Group Audit MadLab // Annual Survey, Postcode Survey, & Community Group Audit - 2017 MadLab makes the impossible seem possible. Methodology // In January 2017, MadLab conducted three surveys: - Annual Survey 291 responses

More information

2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228

2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228 2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228 Vishnu V. B Reddy, MD University of Alabama at Birmingham Birmingham, AL USA 11/03/07

More information

Kathleen Finnegan MS MT(ASCP)SHCM

Kathleen Finnegan MS MT(ASCP)SHCM Kathleen Finnegan MS MT(ASCP)SHCM Discuss the history of hematology automation and digital differentials. Discuss the HemoFAXS Hematology Analysis System by Tissue Gnostics. Review automated microscopy

More information

Curriculum Vitae. Dr. Shruthi Narayan. MBBS, MD (Paediatrics), MRCPCH (UK), FRCPath (Haematology), MSc (Leadership and Service Improvement)

Curriculum Vitae. Dr. Shruthi Narayan. MBBS, MD (Paediatrics), MRCPCH (UK), FRCPath (Haematology), MSc (Leadership and Service Improvement) Curriculum Vitae Dr. Shruthi Narayan MBBS, MD (Paediatrics), MRCPCH (UK), FRCPath (Haematology), MSc (Leadership and Service Improvement) SN 1/6 Personal Particulars Name Contact Address Telephone Number

More information

HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY

HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY HEMATOCRIT Hematocrit is a measure of the percentage of the total blood volume that is made up by the red blood cells The hematocrit can be determined directly

More information

Clinical Guidelines for Leukaemia and other Myeloid Disorders MDS

Clinical Guidelines for Leukaemia and other Myeloid Disorders MDS Clinical Guidelines for Leukaemia and other Myeloid Disorders MDS Reference Number Version Status Executive Lead(s) Name and Job Title Author(s) Name and Job Title 13-2H-106 1 Dr Helen Barker MDT Lead

More information

CONNECTED COUNSELLING Digital mental health and well-being services working with the offline world

CONNECTED COUNSELLING Digital mental health and well-being services working with the offline world CONNECTED COUNSELLING Digital mental health and well-being services working with the offline world Last year and this year I suffered with depression and anger issues so I started using Kooth. Since then

More information

Disclosures. Myeloproliferative Neoplasms: A Case-Based Approach. Objectives. Myeloproliferative Neoplasms. Myeloproliferative Neoplasms

Disclosures. Myeloproliferative Neoplasms: A Case-Based Approach. Objectives. Myeloproliferative Neoplasms. Myeloproliferative Neoplasms Myeloproliferative Neoplasms: A Case-Based Approach Disclosures No conflicts of interests regarding the topic being presented Adam M. Miller, MD PGY-4 Resident Physician Department of Pathology and Laboratory

More information

Academic Clinical Fellowship in Geriatric Medicine

Academic Clinical Fellowship in Geriatric Medicine Academic Clinical Fellowship in Geriatric Medicine Description of ACF Programme: Title: Geriatric Medicine Duration: 3 years Lead NHS Hospital/Trust and contact details: University Hospital Southampton

More information

NHSBT Board September Chief Executive s Board Report

NHSBT Board September Chief Executive s Board Report 16-77 NHSBT Board September 29 2016 Chief Executive s Board Report 1. Status Public 2. Executive Summary This paper summarises key communications activity and highlights other issues of performance and

More information

Case Study: Biomedical Scientist - Caroline

Case Study: Biomedical Scientist - Caroline Case Study: Biomedical Scientist - Caroline What do you do? I'm a biomedical scientist, in haematology. I work in an NHS hospital. We study the morphology of the cells - what they actually look like, such

More information

The LaboratoryMatters

The LaboratoryMatters Laboratory Medicine Newsletter for clinicians, pathologists & clinical laboratory technologists. A Initiative. Complete Blood Count This issue highlights: CBC, while ubiquitous, is an excellent diagnostic

More information

Policy: Client Involvement and Empowerment

Policy: Client Involvement and Empowerment Policy: Client Involvement and Empowerment Updated January 2017 Contents: 1. Introduction 2. How do we involve and empower those to whom we provide housing and/or support? 3. How do we involve and empower

More information

XN series. Case interpretation. Gebruikersdag Vlaanderen- 6 oktober 2016

XN series. Case interpretation. Gebruikersdag Vlaanderen- 6 oktober 2016 XN series Case interpretation Gebruikersdag Vlaanderen- 6 oktober 2016 Fluorescence flow cytometry RET channel PLT-F channel WDF channel WPC channel WNR channel Case 1 Case 1: Initial measurement Patient

More information

Patients as consumers of healthcare: the role of innovation in self-care and self-management

Patients as consumers of healthcare: the role of innovation in self-care and self-management Engineering Innovation in the NHS Royal Academy of Engineering Conference Patients as consumers of healthcare: the role of innovation in self-care and self-management Prof. Lionel Tarassenko FREng Institute

More information

Myeloproliferative Disorders: Diagnostic Enigmas, Therapeutic Dilemmas. James J. Stark, MD, FACP

Myeloproliferative Disorders: Diagnostic Enigmas, Therapeutic Dilemmas. James J. Stark, MD, FACP Myeloproliferative Disorders: Diagnostic Enigmas, Therapeutic Dilemmas James J. Stark, MD, FACP Medical Director, Cancer Program and Palliative Care Maryview Medical Center Professor of Medicine, EVMS

More information

Hematology Unit Lab 1 Review Material

Hematology Unit Lab 1 Review Material Hematology Unit Lab 1 Review Material - 2018 Objectives Laboratory instructors: 1. Assist students during lab session Students: 1. Review the introductory material 2. Study the case histories provided

More information

About Mental Health First Aid

About Mental Health First Aid About Mental Health First Aid Mental Health First Aid (MHFA) courses, first developed in Australia in 2001, provide robust evidence-based training that increase mental health literacy and help turn awareness

More information

10:00 Chair s welcome and opening remarks Richard Caulfield, Regional Director, Association of Colleges

10:00 Chair s welcome and opening remarks Richard Caulfield, Regional Director, Association of Colleges Programme 09:15 Registration and refreshments 10:00 Chair s welcome and opening remarks 10:15 Transforming children and young people s mental health provision Barbara Rayment, Head of Policy, Children

More information

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA. April 16, 2008

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA. April 16, 2008 MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA April 16, 2008 FACULTY COPY GOAL: Learn the appearance of normal peripheral blood elements and lymph nodes. Recognize abnormal peripheral blood

More information

Ordering Physician CLIENT,CLIENT. Collected REVISED REPORT

Ordering Physician CLIENT,CLIENT. Collected REVISED REPORT HPWET Hematopathology Consultation, MML Embed Client Hematopathology Consult REVISED INAL DIAGNOSIS Interpretation Peripheral blood, bone marrow aspirate and biopsies, bilateral iliac crests: 1. Normocellular

More information

Systemic Therapy Re-Imagined: A series of CPD workshops for health and social care professionals (CPD73)

Systemic Therapy Re-Imagined: A series of CPD workshops for health and social care professionals (CPD73) Systemic Therapy Re-Imagined: A series of CPD workshops for health and social care professionals (CPD73) Trust Certificate May - November 2015 Course Type On site Course Length 3 sessions Study Attendance

More information

Scottish Clinical Leadership Fellowship About the SCLF

Scottish Clinical Leadership Fellowship About the SCLF Scottish Clinical Leadership Fellowship About the SCLF Scottish Clinical Leadership Fellowship This guide introduces the Scottish Clinical Leadership Fellowship (SCLF) for doctors and dentists in training,

More information

London Cancer. Myelofibrosis guidelines. August Review August Version v1.0. Page 1 of 12

London Cancer. Myelofibrosis guidelines. August Review August Version v1.0. Page 1 of 12 London Cancer Myelofibrosis guidelines August 2013 Review August 2013 Version v1.0 Page 1 of 12 CONTENTS 1. DIAGNOSIS... 3 1a. BCSH (2012)... 3 1b. WHO (2009) diagnostic criteria for PMF:... 4 2. MOLECULAR

More information

Case scenarios: Patient Group Directions

Case scenarios: Patient Group Directions Putting NICE guidance into practice Case scenarios: Patient Group Directions Implementing the NICE guidance on Patient Group Directions (MPG2) Published: March 2014 [updated March 2017] These case scenarios

More information

Dialogue between Clinician and Pathologist on CBC report

Dialogue between Clinician and Pathologist on CBC report Dialogue between Clinician and Pathologist on CBC report Dr. Seema Bhatwadekar Haematologist, Oncohaematologist & Transplant Physician Vadodara. CBC PBS Most important test to make probable diagnosis Crucial

More information

NES/15/100. This update paper highlights the main areas of work within the Directorate and shows the direction of travel.

NES/15/100. This update paper highlights the main areas of work within the Directorate and shows the direction of travel. NES Item 8c December 2015 NES/15/100 (Enclosure) NHS Education for Scotland Board Paper Summary 1. Title of Paper Optometry within NES Developing Primary Eyecare 2. Author(s) of Paper Dr Janet Pooley,

More information

SPECIALIST REGISTRAR PAEDIATRIC HISTOPATHOLOGY JOB DESCRIPTION. Page 1 of 10

SPECIALIST REGISTRAR PAEDIATRIC HISTOPATHOLOGY JOB DESCRIPTION. Page 1 of 10 SPECIALIST REGISTRAR IN PAEDIATRIC HISTOPATHOLOGY JOB DESCRIPTION SEPTEMBER 2011 Page 1 of 10 THE CENTRAL MANCHESTER UNIVERSITY NHS FOUNDATION TRUST - ROYAL MANCHESTER CHILDREN S HOSPITAL DEPARTMENT OF

More information

Hematology 101. Cindy Rogers, MT(ASCP) Diagnostics System Specialist

Hematology 101. Cindy Rogers, MT(ASCP) Diagnostics System Specialist Hematology 101 Cindy Rogers, MT(ASCP) Diagnostics System Specialist More Acronyms...» CBC» RBC» HGB» HCT» WBC» MPV» PLT» RDW» DIFF» H&H» Complete Blood Count» Red Blood Cell» Hemoglobin» Hematocrit» White

More information

MORPHOLOGY OF BONE MARROW ASPIRATES. Dr.Prasanna N Kumar Head Department of Pathology, Oman Medical College, Oman

MORPHOLOGY OF BONE MARROW ASPIRATES. Dr.Prasanna N Kumar Head Department of Pathology, Oman Medical College, Oman MORPHOLOGY OF BONE MARROW ASPIRATES Dr.Prasanna N Kumar Head Department of Pathology, Oman Medical College, Oman BONE MARROW ASPIRATION Sites Sternum Anterior or posterior iliac spines Aspiration from

More information

STRATEGIC PLAN

STRATEGIC PLAN STRATEGIC PLAN 2016 2020 Promoting and supporting excellence in research www.immunology.org BSI STRATEGY 2016 2020 EXECUTIVE SUMMARY OUR MISSION Our mission is to promote excellence in immunological research,

More information

UK NEQAS Low Level Leucocyte Enumeration Programme. Mr Matthew Fletcher Advanced Biomedical Scientist UK NEQAS for Leucocyte Immunophenotyping

UK NEQAS Low Level Leucocyte Enumeration Programme. Mr Matthew Fletcher Advanced Biomedical Scientist UK NEQAS for Leucocyte Immunophenotyping UK NEQAS Low Level Leucocyte Enumeration Programme Mr Matthew Fletcher Advanced Biomedical Scientist UK NEQAS for Leucocyte Immunophenotyping Content Results of the UKNEQASLI flow cytometry survey Analysis

More information

The Stolen Years Mental Health and Smoking Action Report 22 April Emily James, Policy and Campaigns Officer

The Stolen Years Mental Health and Smoking Action Report 22 April Emily James, Policy and Campaigns Officer The Stolen Years Mental Health and Smoking Action Report 22 April 2016 Emily James, Policy and Campaigns Officer Emily.James@ash.org.uk Where we are now? Overview The Stolen Years: Mental Health and Action

More information